Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

524
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
524
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

569
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
569
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

308
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
308
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

330
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
330
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

1.0K
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

299
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
299

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging Discovery, Mechanism, and Application: An Integrated Strategy for Bioactive Natural Products.

Molecules (Basel, Switzerland)·2026
Same author

Ivermectin effects in cultured endothelial cells from porcine corpus luteum.

Environmental toxicology and pharmacology·2026
Same author

Diagnosis and Treatment of Cystitis in Dogs: An Italian Survey.

Veterinary sciences·2026
Same author

In Vitro Evaluation of Virucidal Effect of Polysaccharides Extracted and Purified from <i>Arthrospira platensis</i> and <i>Dunaliella salina</i> on Human Adenovirus Type 5 in A549 Cells.

Molecules (Basel, Switzerland)·2026
Same author

Protective Effects on Keratinocytes by Extracts Enriched in Polysaccharides from <i>Limnospira platensis</i> Grown Under Autotrophic and Mixotrophic Conditions.

Nutrients·2026
Same author

Influence of management and air quality conditions on development of respiratory and gastroenteric disease, and antibiotics phenotypic resistance in domestic canaries (<i>Serinus canaria domesticus</i>).

Avian pathology : journal of the W.V.P.A·2026
Same journal

Peptidomics in the Spotlight: Advanced Sample Treatment Techniques and Analytical Insights.

Advances in experimental medicine and biology·2026
Same journal

Methods for the Investigation of Protein-Ligands Interactions.

Advances in experimental medicine and biology·2026
Same journal

Sample Preparation Strategies for Microbial Cell Surface Proteomics: Integrating Shaving and Shotgun Approaches.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Sample Preparation for the Petroleum Industry: A Biocorrosion Case Study.

Advances in experimental medicine and biology·2026
Same journal

Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Analysis of Histone Sequence Variants and Post-translationally Modified Forms.

Advances in experimental medicine and biology·2026
See all related articles

Related Experiment Video

Updated: Nov 25, 2025

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

226

Cannabinoid-Based Medicines and Multiple Sclerosis.

Clementina Manera1, Simone Bertini2

  • 1Department of Pharmacy, University of Pisa, Pisa, Italy. clementina.manera@unipi.it.

Advances in Experimental Medicine and Biology
|December 17, 2020
PubMed
Summary
This summary is machine-generated.

Recent studies show the endocannabinoid system (ECS) may help manage multiple sclerosis (MS) symptoms and slow disease progression. Cannabinoids offer potential neuroprotective benefits and new therapeutic avenues for MS treatment.

Keywords:
Arachidonoylethanolamine (AEA) reuptake inhibitorsCannabinoid receptorsEndocannabinoid systemFatty acid amide hydrolase (FAAH) inhibitorsMonoacylglycerol lipase (MAGL) inhibitorsMultiple sclerosis

More Related Videos

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.8K
Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

556

Related Experiment Videos

Last Updated: Nov 25, 2025

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

226
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.8K
Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

556

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Multiple Sclerosis (MS) is a chronic, immune-mediated central nervous system disorder characterized by demyelination.
  • Currently, no cure exists for MS, necessitating research into effective symptom management and disease-modifying therapies.

Purpose of the Study:

  • To review the role of the endocannabinoid system (ECS) in multiple sclerosis.
  • To provide an overview of endogenous and synthetic cannabinoids for symptomatic relief in MS.
  • To explore potential neuroprotective effects and disease-modifying outcomes of cannabinoids in MS.

Main Methods:

  • Literature review of recent studies on the ECS and MS.
  • Analysis of endogenous and synthetic cannabinoids for MS symptom amelioration.
  • Evaluation of reported beneficial outcomes and therapeutic perspectives.

Main Results:

  • The endocannabinoid system (ECS) plays a significant role in managing MS symptoms and progression.
  • Cannabinoids demonstrate potential for symptomatic relief, neuroprotection, and slowing MS disease advancement.
  • Evidence suggests cannabinoids offer promising therapeutic perspectives for MS treatment.

Conclusions:

  • The ECS is a key target for managing multiple sclerosis.
  • Cannabinoids represent a viable therapeutic strategy for improving quality of life and outcomes in MS patients.
  • Further research into cannabinoid-based therapies could lead to novel treatments for multiple sclerosis.